$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Endocrinology
Endocrinology
降糖药DPP4 抑制剂还可以这么用
2025-10-19 11:44:20
Check Details
2型糖尿病患者中丙肝的流行率
2025-10-19 11:44:20
Check Details
美国公司提出糖尿病新药临床试验申请
2025-10-19 11:44:20
Check Details
中国患者:糖尿病、血糖高增加肝病风险
2025-10-19 11:44:20
Check Details
新型降糖药达格列净向日本提交补充性新药申请
2025-10-19 11:44:20
Check Details
癌症患者存在较高糖尿病风险
2025-10-19 11:44:20
Check Details
糖尿病患者患帕金森症的风险较高
2025-10-19 11:44:20
Check Details
糖尿病新药疗效积极
2025-10-19 11:44:20
Check Details
降压药治疗1型糖尿病
2025-10-19 11:44:20
Check Details
新型降糖药补充新药申请审查延迟
2025-10-19 11:44:20
Check Details
糖尿病的严重危害
2025-10-19 11:44:20
Check Details
糖尿病临床试验结果公布
2025-10-19 11:44:20
Check Details
1
2
...
117
118
119
120
121
122
123
...
293
294
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
2
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
3
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
4
Filgotinib JAK1 Inhibitor: RA and Ulcerative Colitis Dosing, Infection/Thrombosis Risks, Pregnancy Contraindication
5
Diazoxide Oral Suspension Inadequate Response: Glucose-Based Titration, Stop at 2–3 Weeks, Re-evaluate Hypoglycemia Cause
6
Trelagliptin Once-Weekly DPP-4 for Type 2 Diabetes: Dosing, Renal Adjustment, Discontinuation
7
Orforglipron (Foundayo) vs Metformin: Oral GLP-1 Weight Loss and T2D Use
8
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor
9
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
10
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
11
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
12
Orforglipron: The World's First Oral Small-Molecule GLP-1 Receptor Agonist for Weight Management